Stemirna Therapeutics

NCT05911087

Phase 2/3, Status unknown, 2023, 800 people, 20 Jun 2023, clinicaltrials.gov

NCT05686161

Phase 3, Status unknown, 2022, 600 people, 17 Jan 2023, clinicaltrials.gov